According to a 2025 report by KBV Research, the global vitamin patch market is projected to reach $714.96 million by 2031, growing at a compound annual rate of 15.4 percent
Store at 20C in a dry, light-protected environment
No published human study tracks continuous use beyond 12 weeks, making extended unsupervised administration an undocumented risk with the current state of evidence on BPC-157
TFCC is a medical term which means triangular fibrocartilage complex that is a combination of ligaments and cartilage structure located in the wrist which holds together the arm bones (the radius and the ulna)
However, overall body weight was still reduced by 5.0% to 9.8% at the end of week 32 in the groups administered cagrilintide and by 7.2% at the end of week 32 in the group administered liraglutide [1]
Continued investigation is exploring its potential across additional tissue types and conditions, but it is essential to keep the framing precise: animal-model and preclinical evidence is not the same as proven human therapy , and BPC-157 has not cleared the bar of FDA approval